Cardiac hormones as diagnostic tools in heart failure

Area of Science:

• Cardiology
• Biochemistry
• Clinical Diagnostics

Background:

• Cardiac hormonal system activation occurs in heart failure due to volume and pressure overload.
• Elevated plasma levels of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and their N-terminal fragments (N-ANP, N-BNP) are characteristic of heart failure.

Purpose of the Study:

• To evaluate the diagnostic and prognostic utility of cardiac hormones in heart failure.
• To assess the role of cardiac hormones in guiding heart failure management and reducing healthcare utilization.

Main Methods:

• Measurement of plasma concentrations of ANP, BNP, N-ANP, and N-BNP.
• Analysis of the predictive values and clinical utility of these biomarkers.

Main Results:

• Elevated cardiac hormone levels identify patients with heart failure and those at high risk for cardiovascular events.
• Cardiac hormones demonstrate high negative predictive value in acutely symptomatic patients, useful for ruling out heart failure.
• Adjusting treatment based on N-BNP levels may enhance patient outcomes.

Conclusions:

• Cardiac hormones are valuable rule-out tests for heart failure, potentially reducing the need for hospitalizations and echocardiography.
• While useful, cardiac hormones are not disease-specific, and interpretation requires consideration of factors like age and gender.
• High levels of cardiac hormones indicate increased risk for serious cardiovascular events and guide risk stratification.